Madewell ZJ, Keita AM, Das PM, Mehta A, Akelo V, Oluoch OB, Omore R, Onyango D, Sagam CK, Cain CJ, Chukwuegbo C, Kaluma E, Luke R, Ogbuanu IU, Bassat Q, Kincardett M, Mandomando I, Rakislova N, Varo R, Xerinda EG, Dangor Z, du Toit J, Lala SG, Madhi SA, Mahtab S, Breines MR, Degefa K, Heluf H, Madrid L, Scott JAG, Sow SO, Tapia MD, El Arifeen S, Gurley ES, Hossain MZ, Islam KM, Rahman A, Mutevedzi PC, Whitney CG, Blau DM, Suchdev PS, Kotloff KL
retatrutide, the biggest difference is that tirzepatide is already FDA-approved while retatrutide is still in clinical trials , though theres a lot of buzz about its potential benefits
doi: 10.3390/pharmaceutics11120681 166 XuHYuWBGaoYZhangMJMalhotraAYuWH
10.1016/j.bmcl.2022.128911 298 YuZ.ChengX.PanW.YuC.DuanY
Exceptional staff